Increased cholesteryl ester transfer protein and changes in lipid metabolism from initiating insulin therapy

Annals of the New York Academy of Sciences

Volumn 947, Issue , 2001, Pages 356-361

  Ai, Masuki ^a   Tanaka, Akira ^a   Baba, Toshiya ^a   Yui, Katsumasa ^a   Numano, Fujio ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Cholesteryl ester transfer protein; Insulin therapy; Lipid metabolism

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HYPERINSULINEMIA; INSULIN TREATMENT; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0035683721     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03962.x     Document Type: Conference Paper

References (15)

1. Plasma cholesteryl ester transfer protein
2. Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus
3. Accelerated cholesteryl ester transfer in noninsulin-dependent diabetes mellitus
4. Effects of multiple daily insulin injections and intraperitoneal insulin therapy on cholesteryl ester transfer and lipoprotein lipase activities in NIDDM
5. Intraperitoneal insulin therapy corrects abnormalities in cholesteryl ester transfer and lipoprotein lipase activities in insulin-dependent diabetes mellitus
6. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
7. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
8. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti B-100 and anti apo A-1 immunoaffinity mixed gels
9. Enzyme immunoassay for cholesteryl ester transfer protein in human serum
10. Purification, microheterogeneity, and stability of human lipid transfer protein
11. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein
12. Increased cholesteryl ester transfer activity in complicated Type 1 (insulin-dependent) diabetes mellitus -its relationship with serum lipids
13. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene
14. Atherosclerotic disease in marked hyperalphalipoproteinemia; combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase
15. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels